Papers

Cochran et al. (2003) Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.

Egerton et al. (2005) Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia.

Morris et al. (2005) PCP: from pharmacology to modelling schizophrenia.

Egerton et al. (2008)  Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Pratt et al. (2008) Modelling prefrontal cortex deficits in schizoprenia:implications for treatment. 

Posters

Paterson et al (2009) An in vitro model for investigating the role of schizophrenia candidate gene ERBB4

Thompson et al (2009) Modafinil reverses PCP-induced deficits in cognitive flexibility

Winchester et al (2009) Polymorphic variants and differential expression of DPYSL2 in schizophrenia

Hunter et al (2010) Impact of negative symptoms on psychosocial functioning in schizophrenia.

Dawson et al (2010) Subchronic Phencyclidine (PCP) treatment produces schizophrenia-like alterations in functional integration and brain network structure in rats.

Thomson et al (2010) Differential effects of PCP in an effort based reward task and a sucrose preference task.